Suppr超能文献

鉴定 MDM2 组成性启动子区域中的功能 DNA 变异。

Identification of functional DNA variants in the constitutive promoter region of MDM2.

机构信息

Division of Hematology-Oncology, Research Center, Sainte-Justine Hospital, 3175 Chemin de la Cote-Sainte-Catherine, Montreal H3T 1C5, Canada.

出版信息

Hum Genomics. 2012 Sep 1;6(1):15. doi: 10.1186/1479-7364-6-15.

Abstract

Although mutations in the oncoprotein murine double minute 2 (MDM2) are rare, MDM2 gene overexpression has been observed in several human tumors. Given that even modest changes in MDM2 levels might influence the p53 tumor suppressor signaling pathway, we postulated that sequence variation in the promoter region of MDM2 could lead to disregulated expression and variation in gene dosage. Two promoters have been reported for MDM2; an internal promoter (P2), which is located near the end of intron 1 and is p53-responsive, and an upstream constitutive promoter (P1), which is p53-independent. Both promoter regions contain DNA variants that could influence the expression levels of MDM2, including the well-studied single nucleotide polymorphism (SNP) SNP309, which is located in the promoter P2; i.e., upstream of exon 2. In this report, we screened the promoter P1 for DNA variants and assessed the functional impact of the corresponding SNPs. Using the dbSNP database and genotyping validation in individuals of European descent, we identified three common SNPs (-1494 G > A; indel 40 bp; and -182 C > G). Three major promoter haplotypes were inferred by using these three promoter SNPs together with rs2279744 (SNP309). Following subcloning into a gene reporter system, we found that two of the haplotypes significantly influenced MDM2 promoter activity in a haplotype-specific manner. Site-directed mutagenesis experiments indicated that the 40 bp insertion/deletion variation is causing the observed allelic promoter activity. This study suggests that part of the variability in the MDM2 expression levels could be explained by allelic p53-independent P1 promoter activity.

摘要

虽然致癌蛋白鼠双微体 2(MDM2)的突变很少见,但在几种人类肿瘤中观察到 MDM2 基因过表达。鉴于 MDM2 水平的微小变化可能会影响 p53 肿瘤抑制信号通路,我们假设 MDM2 启动子区域的序列变异可能导致基因表达失控和基因剂量的变化。已经报道了 MDM2 的两个启动子;一个内部启动子(P2),位于内含子 1 的末端,对 p53 有反应,以及一个上游组成型启动子(P1),对 p53 无依赖性。这两个启动子区域都包含可能影响 MDM2 表达水平的 DNA 变体,包括研究得很好的单核苷酸多态性(SNP)SNP309,它位于启动子 P2 中,即外显子 2 的上游。在本报告中,我们筛选了启动子 P1 中的 DNA 变体,并评估了相应 SNP 的功能影响。使用 dbSNP 数据库和欧洲血统个体的基因分型验证,我们确定了三个常见的 SNP(-1494 G > A;40bp 缺失/插入;-182 C > G)。通过将这三个启动子 SNP 与 rs2279744(SNP309)一起使用,推断出三个主要的启动子单倍型。在亚克隆到基因报告系统后,我们发现其中两个单倍型以特定单倍型的方式显著影响 MDM2 启动子活性。定点突变实验表明,40bp 插入/缺失变异是导致观察到的等位基因启动子活性的原因。这项研究表明,MDM2 表达水平的部分可变性可以用等位基因 p53 非依赖性 P1 启动子活性来解释。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eabf/3500213/851b4ccfc038/1479-7364-6-15-1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验